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A 10% Increase in Step Rate Improves
Running Kinematics and Clinical Outcomes
in Runners With Patellofemoral Pain
at 4 Weeks and 3 Months
Christopher Bramah,*y MSc, MCSP, Stephen J. Preece,y PhD, Niamh Gill,y PhD,
and Lee Herrington,y PhD, MCSP
Investigation performed at the School of Health Sciences, University of Salford, Salford, UK
Background: Aberrant frontal-plane hip and pelvis kinematics have been frequently observed in runners with patellofemoral pain
(PFP). Gait retaining interventions have been shown to improve running kinematics and may therefore be beneficial in runners with
PFP.
Purpose: To investigate whether a 10% increase in the running step rate influences frontal-plane kinematics of the hip and pelvis
as well as clinical outcomes in runners with PFP.
Study Design: Case series; Level of evidence, 4.
Methods: Runners with PFP underwent a 3-dimensional gait analysis to confirm the presence of aberrant frontal-plane hip and/or
pelvis kinematics at baseline. A total of 12 participants with frontal-plane hip and/or pelvis kinematics 1 standard deviation above
a reference database were invited to undergo the gait retraining intervention. Running kinematics along with clinical outcomes of
pain and functional outcomes were recorded at baseline, 4 weeks after retraining, and 3 months. Gait retraining consisted of a sin-
gle session where step rate was increased by 10% using an audible metronome. Participants were asked to continue their normal
running while self-monitoring their step rate using a global positioning system smartwatch and audible metronome.
Results: After gait retraining, significant improvements in running kinematics and clinical outcomes were observed at 4-week and
3-month follow-up. Repeated-measures analysis of variance with post hoc Bonferroni correction (P\ .016) showed significant
reductions in peak contralateral pelvic drop (mean difference [MD], 3.12 [95% CI, 1.88-4.37]), hip adduction (MD, 3.99
[95% CI, 2.01-5.96]), and knee flexion (MD, 4.09 [95% CI, 0.04-8.15]) as well as significant increases in self-reported weekly
running volume (MD, 13.78 km [95% CI, 4.62-22.93 km]) and longest run pain-free (MD, 6.84 km [95% CI, 3.05-10.62 km]). Fried-
man test with a post hoc Wilcoxon signed-rank test showed significant improvements on a numerical rating scale for worst pain in
the past week and the Lower Extremity Functional Scale.
Conclusion: A single session of gait retraining using a 10% increase in step rate resulted in significant improvements in running
kinematics, pain, and function in runners with PFP. These improvements were maintained at 3-month follow-up. It is important to
assess for aberrant running kinematics at baseline to ensure that gait interventions are targeted appropriately.
Registration: NCT03067545 (ClinicalTrials.gov identifier)
Keywords: patellofemoral pain; running; gait retraining; kinematics; step rate
Recreational running is an increasingly popular method of
physical activity, with participation rates growing annu-
ally. Although running offers several health benefits, it
also poses a considerable risk of injury to the musculoskel-
etal system. Overall injury incidence rates are reported to
range between 19% and 78% among recreational run-
ners,37 with recurrence rates in 20% to 70% of all cases.38
Of all running injuries, patellofemoral pain (PFP) is con-
sidered the most common running-related knee injury,36
with incidence and prevalence rates as high as 20.8%
and 22.7%, respectively.34
PFP is known to have a multifactorial cause, with aber-
rant running mechanics identified as one risk factor.21,22,24
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Runners with PFP have been reported to demonstrate
increased hip adduction (HADD),24,25,41 hip internal rota-
tion,25 and contralateral pelvic drop (CPD)41 when com-
pared with injury-free controls. It is thought that
aberrant frontal- and transverse-plane running kinematics
may result in lateral tracking of the patella, leading to
a rise in patellofemoral joint stress.30 When exposed to
repeat loading cycles during running, the knee may expe-
rience damage to the underlying chondral surface, stress
within the subchondral bone, and excitation of nociceptors,
leading to pain and injury.2
Gait retraining is a clinical intervention that targets
aberrant running kinematics within the rehabilitation of
PFP. Current evidence has shown improvements in kine-
matics and clinical outcomes after mirror retraining,42
real-time feedback,26 and transitioning to a forefoot con-
tact.32,33 However, the use of mirror retraining and real-
time feedback is restricted to clinical and laboratory
settings, limiting their practical applicability, while transi-
tioning to a forefoot strike has been shown to increase
Achilles tendon and ankle joint loading, which may
increase the risk of lower limb injury.1 Furthermore, these
studies often utilize a faded feedback design consisting of 8
sessions over a 2-week period, requiring close
clinical supervision. Therefore, there is a need for gait
retraining methods that can be easily integrated outside
of a laboratory setting while providing positive clinical
and biomechanical outcomes.
Increasing step rate may be one method of gait
retraining that could be integrated outside of a laboratory
setting. Through the use of global positioning system
(GPS) smartwatches and mobile metronome applications,
runners may be able to self-retrain and monitor their
step rate without the need for close clinical supervi-
sion.19,40 Currently, only 3 studies have investigated the
effects of increasing the step rate among runners with
PFP.11,12,20 Neal et al20 reported improved frontal-plane
hip and pelvis kinematics along with reductions in pain
but did not investigate whether improvements were main-
tained beyond the 6-week follow-up period. Esculier et al12
reported gait retraining to be no more effective than educa-
tion on load management, and Dos Santos et al11 reported
minimal changes in pain after a 2-week retraining period.
Furthermore, both Esculier et al and Dos Santos et al did
not report any change in frontal-plane hip and pelvis kine-
matics after the retraining period. Therefore, questions
remain regarding the clinical effectiveness of increasing
the step rate and whether step rate retraining results in
long-term kinematic adaptations among runners with
PFP.
The aim of the current study was to investigate whether
a 10% increase in the running step rate influences frontal-
plane kinematics of the hip and pelvis as well as clinical
outcomes in runners with PFP. Rather than use a clinically
monitored faded feedback design, we sought to investigate
whether runners can self-administer gait retraining inter-
ventions using an audible metronome and a GPS smart-
watch. We hypothesized that a 10% increase in step rate
would result in significant reductions in frontal-plane
hip and pelvis kinematics and improvements in clinical
outcomes and that these changes would be present at
short- and long-term follow-up.
METHODS
Participants
Participants were recruited through advertisements
at local sports injury clinics, running clubs, and a
university-based running clinic. Ethical approval for the
study was obtained via the local ethics committee, and
all participants provided written informed consent before
participation. This study was registered as a clinical trial
(ClinicalTrials.gov registration No. NCT03067545) with
enrollment for the trial between March 2017 and Decem-
ber 2018. An a priori sample size calculation was con-
ducted using data from a previous gait retraining study
identifying a 2.3 reduction in CPD after retraining with
an effect size of 1.09.26 Using G*Power software, we calcu-
lated that 12 participants would be required to detect an
effect size of 1.25 with a power of 0.8 and an adjusted critical
alpha of .016. This calculation was based on the use of
paired tests to detect differences in peak CPD, which were
similar to changes observed in previous studies after gait
retraining (2.3)26 and also of similar magnitude to differen-
ces observed between injured and healthy runners (2.7).4
Inclusion/Exclusion Criteria
All participants were required to own a GPS smartwatch
or running watch capable of monitoring step rate. Partici-
pants were included in the gait retraining intervention
based on a 3-stage assessment process. First, a subjective
assessment and clinical examination were used to confirm
the presence of PFP. Once the diagnosis of PFP was con-
firmed, a 3-dimensional (3D) gait analysis was conducted
to confirm the presence of aberrant hip and/or pelvis kine-
matics. To ensure that the injury diagnosis met the consen-
sus definition of a running-related injury,43 participants
had to report an insidious onset of anterior knee pain dur-
ing running lasting for a minimum of 3 months, causing
a self-reported restriction to either their running volume
or duration. Participants were required to be running
a minimum of twice per week, with their worst pain rated
a minimum of 3 out of 10 on a numerical rating scale (NRS)
for pain (0 = no pain, 10 = worst possible pain). Pain must
also have been reproduced by 1 of the additional activi-
ties of squatting, kneeling, prolonged sitting, or ascending
or descending stairs. Participants were excluded if they
reported having any known medical condition, had under-
gone prior musculoskeletal surgery, had a neurological
impairment, had diagnosed knee osteoarthritis, had
a structural deformity of the knee, had an onset of knee
pain caused by trauma or any other sporting activity,
had ceased running, or were undergoing additional treat-
ment outside of the study. To control for training errors
as a potential underlying cause of injury, participants
were also excluded if they reported the onset of symptoms
to occur after an increase in their weekly training volume
30%.23
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After the subjective assessment, participants were
invited to undergo a clinical examination led by the lead
clinician (C.B.) to confirm the diagnosis of PFP in accor-
dance with previously published diagnostic criteria.9 Spe-
cifically, for inclusion in the study, pain must have been
retropatellar or peripatellar in nature and reproduced on
squatting with the exclusion of any patellar instability, lig-
amentous or meniscal injury.9 Pain on squatting has been
shown to have a sensitivity of 91% and a negative predic-
tive value of 74%, suggesting this examination to be the
best available test for PFP.9,27 A combination of additional,
but nonessential, clinical tests was used to further increase
the diagnostic accuracy of PFP.8 Tests included patellar
compression, patellar apprehension, pain on palpation of
the lateral patellar facet, and pain on resisted quadriceps
contraction in 30 of knee flexion.8,27 These tests are known
to have low sensitivity and specificity when used in isolation
and were not used as a sole diagnostic criterion for PFP.8,27
Once the diagnosis of PFP was confirmed, each partici-
pant underwent an initial 3D gait analysis as outlined
below and completed clinical outcome measures to monitor
pain and functional improvements. Clinical outcome meas-
ures included the Lower Extremity Functional Scale
(LEFS), previously validated for use in PFP,3 as well as
self-reported worst pain experienced in the past week
using the NRS (0 = no pain, 10 = worst possible pain). Addi-
tional outcomes monitored were self-reported longest dis-
tance run pain-free and total weekly running volume.
Kinematic Data Collection
Kinematic data were collected from all participants with
confirmed PFP while running on a treadmill (F63; Sole Fit-
ness) at 3.2 m/s wearing their own running shoes. After a 5-
minute warm-up period, 30 seconds of kinematic data were
collected using a 12-camera Oqus system (240 Hz; Qualisys).
A total of 9 anatomic segments were tracked following a pre-
viously published protocol.17,31 Segments included the tho-
rax; pelvis; and bilateral thigh, shank, and foot segments.
Further details of the markers used to track each segment
and the precise definition of the anatomic coordinate systems
are provided in previous publications.13,17,31
Raw kinematic data were low pass filtered at 10 Hz.
Intersegmental kinematics, along with motions of the pel-
vis and thorax with respect to the laboratory system, were
calculated using a 6 degrees of freedom model with Visual3D
software (C-Motion). Gait events were defined using a kine-
matic approach in which initial contact was defined as the
first vertical acceleration peak of either the heel or metatarsal
markers and toe-off defined as the vertical jerk peak of the sec-
ond metatarsal marker.14 Gait events were subsequently used
to segment each kinematic signal into a minimum of 10 con-
secutive gait cycles. An ensemble average for each signal
was created and selected kinematic parameters derived from
the ensemble average curves. This latter processing was car-
ried out using a custom Matlab script (MathWorks).
Participants were invited to participate in the gait
retraining study providing that they demonstrated aber-
rant hip and/or pelvis kinematics during the initial 3D
gait analysis. Aberrant hip and pelvis kinematics were
defined as peak HADD and CPD angles 1 standard devi-
ation above the mean of a previously published database of
healthy recreational runners running at the same speed4
(qualifying criteria = CPD 5.6 and/or HADD 13.2).
Runners who did not meet the kinematic inclusion criteria
were not included in the study and were referred to
a health care professional for further management.
Retraining Protocol
All participants included within the retraining protocol
completed a single 10-minute retraining session conducted
immediately after the initial 3D gait analysis. During the
retraining session, participants were asked to run at the
same speed with a 10% increase in their original step
rate. Step rate was calculated as the number of foot con-
tacts per minute. During the first 5 minutes of the retrain-
ing protocol, participants were instructed to match their
footsteps to an audible metronome set to the new step
rate. For the final 5 minutes of the retraining session,
the audible metronome was removed, and participants
were instructed to continue running at the increased step
rate. Throughout this time, participants were monitored
by the lead researcher to ensure that they were able to
maintain the higher step rate and the metronome reintro-
duced if they failed to do so.
After the retraining session, participants were provided
with instructions for self-administration and monitoring of
the increased step rate. Specifically, during the first 2
weeks, participants were instructed to continue using
a free downloadable metronome application set to the
new step rate. During the third and fourth weeks, partici-
pants were instructed to continue running without the use
of the metronome but were instructed to self-monitor their
cadence using their GPS smartwatch. Participants were
permitted to increase their running volume at any point
in the retraining period provided that any knee pain expe-
rienced was rated below 3 of 10 on an NRS.
All participants were invited to follow-up 3D gait anal-
ysis sessions at 4 weeks and 3 months after the initial
assessment. This follow-up period allowed us to investigate
whether kinematic changes could be maintained across
a time frame comparable with previous gait retraining
studies.42 The follow-up sessions were completed following
the same kinematic testing procedures as the first visit,
recording the same clinical outcome measurements. After
the 4-week follow-up assessment, participants were
instructed to continue running without the use of the met-
ronome. No restrictions to training parameters were pro-
vided; participants were instead instructed to increase
their training volume or pace and change surfaces as
they saw fit provided that any pain experienced was rated
lower than 3 of 10 on the NRS.
Data Analysis
Several kinematic parameters were selected for data anal-
ysis. Kinematic parameters included peak CPD, HADD,
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hip internal rotation, and knee flexion. These parameters
were selected based on previous research highlighting
associations with these parameters and PFP.4,20,25,41
Peak angles at midstance were defined as the maximum
joint angles between initial contact and toe-off. Stride
rate was also included within the analysis, measured as
steps per minute, along with clinical outcome measures
of worst pain experienced in the past week using the
NRS, longest distance run pain-free, total weekly running
volume, and LEFS score.
Statistical Analysis
Repeated-measures analysis of variance was used to assess
for differences in kinematic parameters between the initial
assessment (baseline), 4-week follow-up, and 3-month
follow-up, with a critical alpha of\.05. When significant
differences were observed, post hoc Bonferroni testing,
with an adjusted critical alpha of\.016, was used to iden-
tify differences between time points. Clinical outcomes of
the NRS and LEFS were analyzed using the Friedman
test for nonparametric data with a post hoc Wilcoxon
signed-rank test. Effect sizes were calculated for pairwise
comparisons using the Cohen d and interpreted as 0.2,
0.5, and 0.8 as small, medium, and large, respectively.6
RESULTS
A total of 33 participants met the initial subjective inclu-
sion criteria and were invited for a clinical examination.
After the clinical examination, 18 were diagnosed as hav-
ing PFP and invited to take part in the 3D gait analysis.
After the 3D gait analysis, 12 participants met the inclu-
sion criteria and were enrolled in the gait retraining study.
There were 2 participants who dropped out of the study
between the 4-week and 3-month follow-up points. The
first participant failed to attend the 3-month follow-up
and did not respond to contact, and the second developed
a tibial stress fracture on the same limb and was unable
to continue the study. Both participants were included in
the final analysis using a last observation carried forward
method35 (Table 1).
Kinematics
Repeated-measures analysis of variance showed a signifi-
cant effect of time for several kinematic parameters (Table
2). In particular, there were significant increases in step
rate and reductions in peak CPD, HADD, and knee flexion
after the step rate intervention (Table 2). The post hoc
test revealed that step rate significantly increased by an
average of 11.2% at 4 weeks (mean difference [MD],
18.6 steps/min [95% CI, 11.97-25.23 steps/min]) and
9.2% at 3 months (MD, 15.1 steps/min [95% CI, 10.64-
19.57 steps/min]) when compared with baseline. There
was a significant 3.12 reduction in CPD (MD, 3.12 [95%
CI, 1.88-4.37]) and 3.99 reduction in HADD (MD, 3.99
[95% CI, 2.01-5.96]) at 4 week follow-up, which was
also significant at 3 months when compared with baseline
for both CPD (MD, 2.7 [95% CI, 1.4-4.1]) and HADD
(MD, 2.8 [95% CI, 0.4-5.4]). Similarly, there was a signif-
icant reduction in peak knee flexion during stance phase at
4 weeks (MD, 4.10 [95% CI, 0.04-8.15]) and 3 months
(MD, 4.15 [95% CI, 0.81-7.48]). No significant differen-
ces were observed between the 4-week and 3-month fol-
low-up time points for any of the kinematic parameters
(Table 2).
Clinical and Functional Outcomes
All clinical and functional outcomes demonstrated statisti-
cally significant improvements. Specifically, there was
a significant reduction in pain scores on the NRS from an
average of 6.2 out of 10 at baseline to 1.0 and 0.3 at 4
weeks and 3 months, respectively (x2 = 21.38; P \ .01)
(Figure 1), which is above the minimal clinically important
difference of 1.2 points.28 The LEFS demonstrated a statis-
tically significant improvement from 62.3 at baseline to
76.6 at 4 weeks and 79.7 at 3 months (x2 = 22.29;
P  .01) (Figure 1). When compared with baseline, this
was a 14.3- and 17.4-point improvement at 4 weeks and
3 months, respectively, which is above the minimal clini-
cally important difference of 9 points.3 All participants
demonstrated a significant increase in total weekly run-
ning volume (MD, 13.78 km [95% CI, 4.62-22.93 km]) and
longest distance run pain-free (MD, 6.84 km [95% CI,
3.05-10.62 km]) from baseline to 4-week and 3-month
follow-up (Table 3).
DISCUSSION
The aim of this study was to investigate whether a 10%
increase in the step rate would improve kinematics and
clinical outcomes among runners with PFP who demon-
strate aberrant frontal-plane pelvis and hip kinematics.
In support of our hypothesis, we observed significant
reductions in frontal-plane pelvis and hip kinematics as
well as significant reductions in pain and improvements
in function and running at 4 weeks, which appeared to
be maintained at 3-month follow-up.
After the step rate increase, we observed a 3.12 and
3.99 reduction in CPD and HADD, respectively (Table
2), which may offer a mechanical explanation for the
TABLE 1
Participant Characteristicsa
Value
Male/female sex, n 4/8
Age, y 39.92 6 6.50
Weight, kg 61.03 6 6.48
Height, cm 170.33 6 6.98
Usual weekly running volume, km 29.03 6 8.11
aValues are presented as mean6 SD unless otherwise specified.
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improved clinical outcomes seen in this study. These
changes are greater than those observed in previous step
rate studies,11,20 with this being the first study to highlight
that kinematic adaptations are maintained at longer term
follow-up. CPD and HADD have been cited as kinematic
risk factors for PFP.4,21,24,25,41 It is thought that CPD
will give rise to an increase in iliotibial band tension,
resulting in lateral displacement of the patella,15,18 while
HADD would cause the femur to shift medially under the
patella.29 This would result in elevated contact pressure
between the patella and lateral facet, leading to elevated
joint stress and potential injury.30 Therefore, it is possible
that the reductions in CPD and HADD after an increase in
the step rate would contribute to reduced lateral displace-
ment of the patella and a corresponding reduction in patel-
lofemoral joint stress.
Similarly, the reduction in peak knee flexion during
stance phase may also contribute to improvements in clin-
ical outcomes. Peak knee flexion during stance phase has
been shown to influence patellofemoral joint reaction force,
explaining up to 64% of the variance in peak patellofe-
moral joint loading.16 Smaller knee flexion angles at mid-
stance will likely reduce the external joint force as well
as reduce the demand on the surrounding musculature.16
In the current study, we observed a 4.1 reduction in peak
knee flexion (Table 2). Given the work of Lenhart et al,16
TABLE 2
Kinematic Parametersa
Baseline 4 wk 3 mo P Value (ANOVA) Pairwise Effect Size (Cohen d)
Stride rate, steps/min 165.93 6 7.38 184.53 6 10.10b 181.04 6 7.78b \.01 Baseline to 4 wk 2.10
Baseline to 3 mo 1.99
4 wk to 3 mo 0.38
Peak CPD, deg 7.46 6 1.81 4.34 6 2.47b 4.73 6 2.95b \.01 Baseline to 4 wk 1.44
Baseline to 3 mo 1.11
4 wk to 3 mo 0.14
Peak HADD, deg 15.95 6 2.75 11.96 6 1.77b 13.09 6 3.20b \.01 Baseline to 4 wk 1.72
Baseline to 3 mo 0.95
4 wk to 3 mo 0.43
Peak hip internal rotation, deg 4.06 6 8.17 4.18 6 9.35 4.42 6 7.89 .93 Baseline to 4 wk 0.01
Baseline to 3 mo 0.04
4 wk to 3 mo 0.02
Peak knee flexion, deg 33.74 6 5.25 29.64 6 3.23b 29.59 6 3.16b \.01 Baseline to 4 wk 0.94
Baseline to 3 mo 0.96
4 wk to 3 mo 0.02
aValues are presented as mean 6 SD unless otherwise specified. Pairwise effect sizes are interpreted as 0.2 = small, 0.5 = medium, and
0.8 = large. ANOVA, analysis of variance; CPD, contralateral pelvic drop; HADD, hip adduction.
bSignificant difference when compared with baseline at P\ .016 after Bonferroni correction.
Figure 1. Clinical outcomes at baseline, 4 weeks, and 3 months. *Statistically significant difference when compared with baseline
at P\ .016. Error bars represent 61 standard deviation.
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this magnitude of change is likely to contribute to reduc-
tions in peak patellofemoral joint force. These reductions,
combined with the reductions in peak HADD and CPD,
will likely lead to significant reductions in patellofemoral
joint stress, which may explain the observed improvements
in clinical outcomes within the present study.
We suggest that the improved frontal-plane hip and pel-
vis kinematics may be explained by alterations in neuro-
muscular activity of the hip. Willson et al39 found that
runners with PFP demonstrate significantly delayed onset
of the gluteus medius, which had a moderate correlation
with HADD excursion. It is hypothesized that delayed
muscle activation of the gluteus medius during the stance
phase of running would result in a loss of neuromuscular
stiffness about the hip and pelvis, leading to a loss of
frontal-plane stability.39 Increasing step rate by 10% has
been shown to directly influence the preactivation of glu-
teal muscles.5 Specifically, Chumanov et al5 reported sig-
nificantly increased gluteus medius and maximus muscle
activity in late swing phase, just before initial foot contact
after a 10% increase in step rate. Considering the role that
the gluteus medius plays in frontal-plane stability of the
hip and pelvis, it is likely that the earlier onset of the
gluteal muscles would result in increased neuromuscular
stability during the stance phase of gait. This would likely
explain the mechanical improvements of reduced CPD and
HADD observed in the present study.
Reductions in peak knee flexion may also be explained
by alterations in neuromuscular activity at the knee.
Increasing the step rate has been shown to result in
greater preactivation of the hamstrings, vastus lateralis,
and rectus femoris muscles during late swing phase.5 It
is thought that these changes in neuromuscular coordina-
tion contribute to a more extended knee throughout the
stance phase, reducing peak knee flexion angles.5,16
In contrast to previous studies, we did not identify dif-
ferences in peak hip internal rotation after gait retraining.
Neal et al20 reported a 5.1 reduction in peak hip internal
rotation after a 10% increase in step rate, whereas in the
present study, we did not observe more than a 0.5 change.
This may be explained by our baseline inclusion criteria of
increased HADD and CPD rather than hip internal rota-
tion. Participants within this study demonstrated 4.06 of
hip internal rotation at baseline, which is less than the
9.1 reported in the study by Neal et al20 and similar to
the 4.4 reported in the database of healthy runners used
for baseline reference values.4 Therefore, it is possible
that participants in the present study did not demonstrate
increased hip internal rotation angles at baseline and thus
would be unlikely to demonstrate any change.
An interesting finding was the magnitude of clinical
improvements made by participants. Specifically, partici-
pants reported their worst pain to be, on average, 1.0 out
of 10 at 4-week follow-up and 0.3 out of 10 at 3-month fol-
low-up (Figure 1). This is greater than the minimal clini-
cally important difference of 1.2 points28 and greater
than improvements seen in previous step rate studies,
which have reported average NRS scores of 3,11 3.8,12
and 2.920 out of 10 after retraining. We also observed sig-
nificant improvements in function, with all runners report-
ing an increase in their weekly running volume and
longest distance run pain-free as early as 4 weeks (Table
3), as well as a 17.4-point improvement on the LEFS at 3
months, exceeding the minimal clinically important differ-
ence of 9 points.3 This contrasts with previous step rate
studies, with 1 study reporting participants to be running
less than their preinjury status at 20-week follow-up12 and
another study reporting less than a 9-point improvement
on the LEFS.11
The reason for the magnitude of kinematic and clinical
improvements in the present study compared with previ-
ous step rate studies may be because of the differences in
inclusion criteria. In the present study, we specifically tar-
geted participants who demonstrated aberrant kinematics
at baseline. We did this to account for the multifactorial
etiology of PFP and ensure that the appropriate underly-
ing injury driver was targeted through the gait interven-
tion. Failure to consider alternative causes of injury
would likely result in the inclusion of biomechanical non-
responders in the retraining group. As such, these partici-
pants would be unlikely to demonstrate significant clinical
improvements. Willy et al42 and Noehren et al26 are the
only previous studies to use a similar inclusion criterion,
with their results showing a similar magnitude of clinical
improvement. Therefore, we suggest that future research
should aim to establish the underlying pathological driver
to appropriately target clinical interventions and that this
be mirrored in clinical practice.
TABLE 3
Functional Outcomesa
Parameter Baseline 4 wk 3 mo P Value Pairwise Effect Size (Cohen d)
Total distance per week, km 13.34 6 9.83 27.11 6 11.25b 28.33 6 12.96b \.01 Baseline to 4 wk 1.30
Baseline to 3 mo 1.30
4 wk to 3 mo 0.10
Longest run pain-free, km 2.03 6 1.19 8.87 6 4.39b 11.33 6 6.42b \.01 Baseline to 4 wk 2.10
Baseline to 3 mo 2.01
4 wk to 3 mo 0.44
aValues are presented as mean 6 SD unless otherwise specified. Pairwise effect sizes are interpreted as 0.2 = small, 0.5 = medium, and
0.8 = large.
bStatistically significant difference when compared with baseline at P\ .016.
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Clinical Relevance
In contrast to previous gait retraining studies, we opted to
allow runners to self-administer and self-monitor their
retraining using a metronome application and feedback
from a GPS smartwatch. This proved successful, as all run-
ners were able to maintain an increased cadence at 4-week
and 3-month follow-up. Furthermore, at 4-week follow-up,
all participants reported that they did not use the metronome
beyond the first week and instead self-monitored their
cadence using their GPS smartwatch. Previous studies have
utilized a faded feedback design in which feedback is gradu-
ally removed over 8 sessions across a 2-week period. Although
faded feedback designs have proven clinically effective, they
require close clinical supervision and are restricted to clinical
and laboratory settings. The present study demonstrates that
simple step rate retraining can be applied outside of the lab-
oratory and with minimal clinical contact. Importantly, 2-
dimensional measures of CPD and HADD have been shown
to be valid and reliable when compared with 3D measure-
ments.10 Therefore, assessment of running kinematics and
gait retraining can be easily integrated into clinical practice
and a participant’s normal running routine.
Limitations
One limitation of the present study is the lack of a control
group, making it difficult to ascertain whether the
observed findings are true intervention effects. However,
participants in the present study had an average NRS
pain score of 6.2 out of 10 at baseline and a minimum
symptom duration of 3 months, which has been reported
to be predictive of poor prognosis at long-term follow-up.7
Therefore, it is unlikely that participants would have expe-
rienced the magnitude of symptom improvement without
a clinical intervention. Furthermore, the kinematic differ-
ences observed between baseline and the 4-week and 3-
month time points were statistically significant, with large
effect sizes above the standard error of measurement pre-
viously reported for these parameters.17 These differences
were of a similar magnitude to those observed previously
between injured and healthy runners (2.7)4 and after
gait retraining interventions (2.3).26 Therefore, we believe
that the differences observed represent true intervention
effects and could be considered biomechanically important.
A second limitation is the small participant numbers,
which makes the statistical interpretation of small differen-
ces difficult. We observed no significant kinematic changes
between 4-week and 3-month follow-up. We acknowledge
that the small sample size limited the statistical power to
detect small differences between these time points. How-
ever, the magnitude of the differences in biomechanical out-
comes between these 2 follow-up points was typically small
(Table 2) and lower than the standard error of measurement
previously reported for these parameters.17 Therefore,
we believe that subtle differences between these time
points are unlikely to be clinically important. However,
we acknowledge that future randomized controlled trials
with larger participant numbers are necessary to further
validate our findings and confirm that kinematic changes
are maintained over longer time periods.
It is important to note that 1 participant dropped out of
the intervention after suffering a tibial stress fracture.
This participant reported that the injury onset occurred
after a sudden increase in training volume in preparation
for a half-marathon. As we did not control participant pro-
gression of training volume, it is possible that the injury
could be the result of training behaviors rather than
a response to the intervention. As such, we recommend
that future clinical interventions provide participants
with specific advice on the safe progression of running vol-
ume to reduce the risk of further injuries.
CONCLUSION
The results of this study highlight that a 10% increase in
step rate improves running kinematics and clinical out-
comes at 4 weeks, which are maintained at 3 months,
among runners with PFP. Therefore, step rate retraining
appears to be a clinically effective intervention in the reha-
bilitation of PFP and can easily be integrated into clinical
practice. It is important to assess running kinematics at
baseline to ensure that interventions are appropriately
targeted.
REFERENCES
1. Almonroeder T, Willson JD, Kernozek TW. The effect of foot strike
pattern on Achilles tendon load during running. Ann Biomed Eng.
2013;41(8):1758-1766.
2. Besier TF, Gold GE, Delp SL, Fredericson M, Beaupre GS. The influ-
ence of femoral internal and external rotation on cartilage stresses
within the patellofemoral joint. J Orthop Res. 2008;26(12):1627-1635.
3. Binkley JM, Stratford PW, Lott SA, Riddle DL. The Lower Extremity
Functional Scale (LEFS): scale development, measurement proper-
ties, and clinical application. North American Orthopaedic Rehabilita-
tion Research Network. Phys Ther. 1999;79(4):371-383.
4. Bramah C, Preece SJ, Gill N, Herrington L. Is there a pathological gait
associated with common soft tissue running injuries? Am J Sports
Med. 2018;46(12):3023-3031.
5. Chumanov ES, Wille CM, Michalski MP, Heiderscheit BC. Changes in
muscle activation patterns when running step rate is increased. Gait
Posture. 2012;36(2):231-235.
6. Cohen J. Statistical Power Analysis for the Behavioral Sciences:
Revised Edition. New York: Academic Press; 1977.
7. Collins NJ, Bierma-Zeinstra SM, Crossley KM, van Linschoten RL,
Vicenzino B, van Middelkoop M. Prognostic factors for patellofemoral
pain: a multicentre observational analysis. Br J Sports Med.
2013;47(4):227-233.
8. Cook C, Hegedus E, Hawkins R, Scovell F, Wyland D. Diagnostic
accuracy and association to disability of clinical test findings associ-
ated with patellofemoral pain syndrome. Physiother Can. 2010;
62(1):17-24.
9. Crossley KM, Stefanik JJ, Selfe J, et al. 2016 patellofemoral pain
consensus statement from the 4th International Patellofemoral Pain
Research Retreat, Manchester, part 1: terminology, definitions, clini-
cal examination, natural history, patellofemoral osteoarthritis and
patient-reported outcome measures. Br J Sports Med. 2016;
50(14):839-843.
10. Dingenen B, Staes FF, Santermans L, et al. Are two-dimensional
measured frontal plane angles related to three-dimensional mea-
sured kinematic profiles during running? Phys Ther Sport.
2018;29:84-92.
AJSM Vol. XX, No. X, XXXX Gait Retraining Improves Outcomes in Runners With PFP 7
11. Dos Santos AF, Nakagawa TH, Lessi GC, et al. Effects of three gait
retraining techniques in runners with patellofemoral pain. Phys Ther
Sport. 2019;36:92-100.
12. Esculier JF, Bouyer LJ, Dubois B, et al. Is combining gait retraining or
an exercise programme with education better than education alone
in treating runners with patellofemoral pain? A randomised clinical tri-
al. Br J Sports Med. 2018;52(10):659-666.
13. Foch E, Milner CE. Frontal plane running biomechanics in female run-
ners with previous iliotibial band syndrome. J Appl Biomech.
2014;30(1):58-65.
14. Handsaker JC, Forrester SE, Folland JP, Black MI, Allen SJ. A kinematic
algorithm to identify gait events during running at different speeds and
with different footstrike types. J Biomech. 2016;49(16):4128-4133.
15. Herrington L, Law J. The effect of hip adduction angle on patellar
position measured using real time ultrasound scanning. Knee.
2012;19(5):709-712.
16. Lenhart RL, Thelen DG, Wille CM, Chumanov ES, Heiderscheit BC.
Increasing running step rate reduces patellofemoral joint forces.
Med Sci Sports Exerc. 2014;46(3):557-564.
17. Mason DL, Preece SJ, Bramah CA, Herrington LC. Reproducibility of
kinematic measures of the thoracic spine, lumbar spine and pelvis
during fast running. Gait Posture. 2016;43:96-100.
18. Merican AM, Amis AA. Iliotibial band tension affects patellofemoral
and tibiofemoral kinematics. J Biomech. 2009;42(10):1539-1546.
19. Napier C, Esculier JF, Hunt MA. Gait retraining: out of the lab and
onto the streets with the benefit of wearables. Br J Sports Med.
2017;51(23):1642-1643.
20. Neal BS, Barton CJ, Birn-Jeffrey A, Daley M, Morrissey D. The effects
& mechanisms of increasing running step rate: a feasibility study in
a mixed-sex group of runners with patellofemoral pain. Phys Ther
Sport. 2018;32:244-251.
21. Neal BS, Barton CJ, Gallie R, O’Halloran P, Morrissey D. Runners
with patellofemoral pain have altered biomechanics which targeted
interventions can modify: a systematic review and meta-analysis.
Gait Posture. 2016;45:69-82.
22. Neal BS, Lack SD, Lankhorst NE, Raye A, Morrissey D, van Middel-
koop M. Risk factors for patellofemoral pain: a systematic review and
meta-analysis. Br J Sports Med. 2019;53(5):270-281.
23. Nielsen RO, Parner ET, Nohr EA, Sorensen H, Lind M, Rasmussen S.
Excessive progression in weekly running distance and risk of
running-related injuries: an association which varies according to
type of injury. J Orthop Sports Phys Ther. 2014;44(10):739-747.
24. Noehren B, Hamill J, Davis I. Prospective evidence for a hip etiology
in patellofemoral pain. Med Sci Sports Exerc. 2013;45(6):1120-1124.
25. Noehren B, Pohl MB, Sanchez Z, Cunningham T, Lattermann C.
Proximal and distal kinematics in female runners with patellofemoral
pain. Clin Biomech. 2012;27(4):366-371.
26. Noehren B, Scholz J, Davis I. The effect of real-time gait retraining on
hip kinematics, pain and function in subjects with patellofemoral pain
syndrome. Br J Sports Med. 2011;45(9):691-696.
27. Nunes GS, Stapait EL, Kirsten MH, de Noronha M, Santos GM. Clin-
ical test for diagnosis of patellofemoral pain syndrome: systematic
review with meta-analysis. Phys Ther Sport. 2013;14(1):54-59.
28. Piva SR, Gil AB, Moore CG, Fitzgerald GK. Responsiveness of the
activities of daily living scale of the knee outcome survey and
numeric pain rating scale in patients with patellofemoral pain. J
Rehabil Med. 2009;41(3):129-135.
29. Powers CM, Ward SR, Fredericson M, Guillet M, Shellock FG.
Patellofemoral kinematics during weight-bearing and non-weight-
bearing knee extension in persons with lateral subluxation of the
patella: a preliminary study. J Orthop Sports Phys Ther. 2003;
33(11):677-685.
30. Powers CM, Witvrouw E, Davis IS, Crossley KM. Evidence-based
framework for a pathomechanical model of patellofemoral pain:
2017 patellofemoral pain consensus statement from the 4th Interna-
tional Patellofemoral Pain Research Retreat, Manchester, UK, part 3.
Br J Sports Med. 2017;51(24):1713-1723.
31. Preece SJ, Mason D, Bramah C. The coordinated movement
of the spine and pelvis during running. Hum Mov Sci. 2016;45:
110-118.
32. Roper JL, Harding EM, Doerfler D, et al. The effects of gait retraining
in runners with patellofemoral pain: a randomized trial. Clin Biomech
(Bristol, Avon). 2016;35:14-22.
33. Sinclair JK. Effects of a 10 week footstrike transition in habitual rear-
foot runners with patellofemoral pain. Comp Exerc Physiol. 2016;
12(3):141-150.
34. Smith BE, Selfe J, Thacker D, et al. Incidence and prevalence of
patellofemoral pain: a systematic review and meta-analysis. PLoS
One. 2018;13(1):e0190892.
35. Streiner D, Geddes J. Intention to treat analysis in clinical trials when
there are missing data. Evid Based Ment Health. 2001;4(3):70-71.
36. Taunton JE, Ryan MB, Clement D, McKenzie DC, Lloyd-Smith D,
Zumbo B. A retrospective case-control analysis of 2002 running inju-
ries. Br J Sports Med. 2002;36(2):95-101.
37. van Gent RN, Siem D, van Middelkoop M, et al. Incidence and deter-
minants of lower extremity running injuries in long distance runners:
a systematic review. Br J Sports Med. 2007;41(8):469-480.
38. van Mechelen W. Running injuries: a review of the epidemiological lit-
erature. Sports Med. 1992;14(5):320-335.
39. Willson JD, Kernozek TW, Arndt RL, Reznichek DA, Scott Straker J.
Gluteal muscle activation during running in females with and without
patellofemoral pain syndrome. Clin Biomech (Bristol, Avon). 2011;
26(7):735-740.
40. Willy RW, Buchenic L, Rogacki K, Ackerman J, Schmidt A, Willson
JD. In-field gait retraining and mobile monitoring to address running
biomechanics associated with tibial stress fracture. Scand J Med Sci
Sports. 2016;26(2):197-205.
41. Willy RW, Manal KT, Witvrouw EE, Davis IS. Are mechanics different
between male and female runners with patellofemoral pain? Med Sci
Sports Exerc. 2012;44(11):2165-2171.
42. Willy RW, Scholz JP, Davis IS. Mirror gait retraining for the treatment
of patellofemoral pain in female runners. Clin Biomech. 2012;
27(10):1045-1051.
43. Yamato TP, Saragiotto BT, Lopes AD. A consensus definition of
running-related injury in recreational runners: a modified Delphi
approach. J Orthop Sports Phys Ther. 2015;45(5):375-380.
For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.
8 Bramah et al The American Journal of Sports Medicine
